.Amgen has shared (PDF) the 1st phase 3 information on its $400 thousand chronic eczema drug, linkin...
.Biogen and UCB's bank on advancing into stage 3 on the back of a broken study aims to have actually...
.Italian biotech Aptadir Therapeutics has released along with the pledge that its own pipeline of pr...
.Wave Life Sciences has met its own goal in a Duchenne muscular dystrophy (DMD) research study, posi...
.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, using up the ...
.Achilles Therapeutics has actually shreded its own approach. The British biotech is stopping work o...
.Aligos Therapies is actually proclaiming a midstage win in metabolic-dysfunction linked steatohepat...
.Basilea Pharmaceutica's job developing brand-new antifungals has received a notable improvement com...
.Possessing already gathered up the U.S. civil rights to Capricor Rehabs' late-stage Duchenne muscle...
.After pushing the selection date for Applied Therapies' metabolic condition medication govorestat, ...